South-South entrepreneurial collaboration in health biotech

Nature Biotechnology

Volumn 28, Issue 5, 2010, Pages 407-416

  Thorsteinsdóttir, Halla ^a   Melon, Christina C ^a   Ray, Monali ^a   Chakkalackal, Sharon ^a   Li, Michelle ^a   Cooper, Jan E ^a   Chadder, Jennifer ^a   Saenz, Tirso W ^b   De Souza Paula, Maria Carlota ^b   Ke, Wen ^c   Li, Lexuan ^c   Madkour, Magdy A ^d   Aly, Sahar ^e   El Nikhely, Nefertiti ^e   Chaturvedi, Sachin ^f   Konde, Victor ^g   Daar, Abdallah S ^a   Singer, Peter A ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF BRASILIA   (Brazil)

^c Chinese Academy of Sciences   (China)

^d AIN SHAMS UNIVERSITY   (Egypt)

^e BIBLIOTHECA ALEXANDRINA   (Egypt)

^f Research and Information System for Developing Countries   (India)

^g UNIVERSITY OF ZAMBIA   (Zambia)

Author keywords

[No Author keywords available]

Indexed keywords

MENINGITIS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BIOTECHNOLOGY; CHINA; DEVELOPING COUNTRY; ECONOMIC ASPECT; EPIDEMIC; GEOGRAPHY; GOVERNMENT; HEALTH CARE ORGANIZATION; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; INFECTION PREVENTION; INTERNATIONAL COOPERATION; MENINGITIS; PRIORITY JOURNAL; REVIEW; SOUTH AFRICA; SOUTHEAST ASIA; WORLD HEALTH ORGANIZATION;

AFRICA; BIOTECHNOLOGY; BRAZIL; CHINA; CLINICAL TRIALS AS TOPIC; COOPERATIVE BEHAVIOR; DEVELOPING COUNTRIES; GEOGRAPHY; HEALTH CARE SECTOR; HUMANS; MENINGOCOCCAL VACCINES; THAILAND; WORLD HEALTH;

EID: 77952208483     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt0510-407     Document Type: Review

References (28)

1. Anonymous. South-south trade: vital for development (Policy brief) (Organisation for Economic Co-Operation and Development, Paris, 2006)
2. Anonymous. Global economic prospects: crisis, finance, and growth (The International Bank for Reconstruction and Development & The World Bank, Washington, DC, 2010)
3. Hassan, M.H. Building capacity in the life sciences in the developing world. Cell 131, 433-436 (2007). (Pubitemid 350011191)
4. Mkoka, C. South African scientists welcome Malawi on board. SciDev.Net (17 August 2007).
5. Thorsteinsdóttir, H., Quach, u., Daar, A.S. & Singer, P.A. Conclusions: promoting biotechnology innovation in developing countries. Nat. Biotechnol. 22 suppl., DC48-DC52 (2004).
6. Frew, S.E. et al. India's health biotech sector at a crossroads. Nat. Biotechnol. 25, 403-417 (2007).
7. Frew, S.E. et al. Chinese health biotech and the three-billion patient market. Nat. Biotechnol. 26, 37-53 (2008).
8. Rezaie, R. et al. Brazilian health biotech-fostering crosstalk between public and private sectors. Nat. Biotechnol. 26, 627-644 (2008). (Pubitemid 351809583)
9. Al-Bader, S. et al. Small but tenacious: South Africa's health biotech sector. Nat. Biotechnol. 27, 427-445 (2009).
10. Morel, C.M. et al. Health innovation networks to help developing countries address neglected diseases. Science 309, 401-404 (2005).
11. Lemle, M. Nations team up to share R & D skills in HIV/AIDS battle. SciDev.Net (28 February 2005)
12. Ohiorhenuan, J.F.E. & Rath, A. in Desigining the Future: South-South Cooperation in Science and Technology (eds. Zhou, Y. & Gitta, C.) (united Nations Development Programme, New York, 2000)
13. Pisano, G.P. Science Business: The Promise, the Reality, and the Future of Biotech (Harvard Business School Press, Boston, 2006)
14. Hagedoorn, J. Inter-firm R&D partnerships: an overview of major trends and patterns since 1960. Res. Policy 31, 477-492 (2002). (Pubitemid 34286933)
15. Faulkner, W. & Senker, J. Knowledge Frontiers: Public Sector Research and Industrial Innovation in Biotechnology, Engineering Ceramics and Parallel Computing (Oxford university Press, 1995).
16. Lee, C.W. Strategic alliances influence on small and medium firm performance. J. Bus. Res. 60, 731-741 (2007).
17. Roijakkers, N. & Hagedoorn, J. Inter-firm R&D partnering in pharmaceutical biotechnology since 1975: Trends, patterns, and networks. Res. Policy 35, 431-446 (2006).
18. van Beuzekom, B. & Arundel, A. OECD biotechnology statistics (Organisation for Economic Co-Operation and Development, Paris, 2006).
19. Yusuf, S., Nabeshima, K. & Perkins, D. in Dancing with Giants: China, India and the Global Economy (eds. Winteres, L.A. & Ysuf, S.) 35-66 (The World Bank, Washington, DC, and the Institute of Policy Studies, Singapore, 2007).
20. Chaturvedi, K., Chataway, J. & Wield, D. Policy, markets and knowledge: strategic synergies in Indian pharmaceutical firms. Technol. Anal. Strateg. Manage. 19, 565-588 (2007). (Pubitemid 47393877)
21. Bower, D.J. & Sulej, J.C. The Indian challenge: the evolution of a successful new global strategy in the pharmaceutical industry. Technol. Anal. Strateg. Manage. 19, 611-624 (2007).
22. Maiti, R. & Raghavendra, M. Clinical trials in India. Pharmacol. Res. 56, 1-10 (2007). (Pubitemid 46990927)
23. Ray, M., Daar, A.S., Singer, P.A. & Thorsteinsdóttir, H. Globetrotting firms. a survey of Canada's health biotechnology collaboration with developing countries. Nat. Biotechnol. 27, 806-814 (2009).
24. Kale, D. & Little, S. From imitation to innovation: the evolution of R&D capabilities and learning processes in the Indian pharmaceutical industry.Technol. Anal. Strateg. Manage. 19, 589-609 (2007). (Pubitemid 47393878)
25. Simonetti, R. & Archambault, E. The dynamics of pharmaceutical patenting in India: evidence from uSPTO data.Technol. Anal. Strateg. Manage. 19, 625-642 (2007). (Pubitemid 47393880)
26. Thorsteinsdóttir, H. The role of the health system in health biotechnology in developing countries. Technol. Anal. Strateg. Manage. 19, 659-675 (2007). (Pubitemid 47393882)
27. Taylor, A.D. et al. North-South partnerships\a study of Canadian firms. Nat. Biotechnol. 25, 978-979 (2007).
28. Sangkitporn, S. et al. Efficacy and safety of zidovu-dine and zalcitabine combined with a combination of herbs in the treatment of HIV-infected Thai patients. Southeast Asian J. Trop. Med. Public Health 36, 704-708 (2005). (Pubitemid 41316798)